3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
44
Breast Neoplasms
30
Lymphoma
29
Sarcoma
27
Hodgkin Disease
24
Triple Negative Breast Neoplasms
20
Burkitt Lymphoma
20
Precursor Cell Lymphoblastic Leukemia-Lymphoma
19
Lymphoma, Follicular
16
Neoplasms
15
Ovarian Neoplasms
14
Lymphoma, B-Cell
14
Lymphoma, Non-Hodgkin
13
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
9
Lymphoma, T-Cell, Peripheral
9
Endometrial Neoplasms
9
Neuroblastoma
7
Neoplasm Metastasis
7
Lymphoma, Mantle-Cell
7
Liposarcoma
7
Leukemia
7
Fallopian Tube Neoplasms
7
Recurrence
6
Multiple Myeloma
6
Leiomyosarcoma
6
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
5
Osteosarcoma
5
Lymphoma, B-Cell, Marginal Zone
5
Leukemia, Lymphocytic, Chronic, B-Cell
5
Inflammatory Breast Neoplasms
5
Interventions
Magnetic Resonance Spectroscopy
5
trametinib
3
Specimen Handling
3
dabrafenib
2
cabozantinib
2
X-Rays
2
Iodine-131
2
Interviews as Topic
2
tremelimumab
1
spartalizumab
1
pembrolizumab
1
omipalisib
1
lenvatinib
1
gallium Ga 68 dotatate
1
durvalumab
1
cobimetinib
1
Vemurafenib
1
Thyrotropin Alfa
1
Sodium Iodide
1
Phantoms, Imaging
1
Nivolumab
1
Ipilimumab
1
Iodine-124
1
High-Energy Shock Waves
1
Glycoprotein Hormones, alpha Subunit
1
Counseling
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Adenocarcinoma, Follicular
×
Doxorubicin
×
1 year
×
Clear all
No trials found.